Top Tweets for #PharmaShots
@DaiichiSankyo Submits sNDA to Japan’s MHLW for Enhertu to Treat HER2 Expressing Uterine Carcinosarcoma.
#DaiichiSankyo #Enhertu #TrastuzumabDeruxtecan #sNDA #UterineCarcinosarcoma #HER2Expression #STATICETrial #Phase2Data #AntibodyDrugConjugate #PharmaShots
https://t.co/17Kwo6Ep3a
The US FDA Grants 510(k) Clearance to Bracco and @AvicennaAi UPTUNITY Aneurysm for Brain Aneurysm Detection.
#Bracco #AvicennaAI #UPTUNITYAneurysm #FDA510KClearance #ArtificialIntelligence #BrainAneurysm #CerebralCTA #RadiologyAI #MedicalImaging #PharmaShots
https://t.co/pVTalk5Sae
@CoEisai and @bioarcticab Launch Leqembi Pen (Subcutaneous Lecanemab) in Japan for Early Alzheimer’s Disease.
#BioArctic #Eisai #LeqembiPen #Lecanemab #AlzheimersDisease #SubcutaneousFormulation #AntiAmyloidTherapy #AtHomeTreatment #JapanLaunch #PharmaShots
https://t.co/h7fz6cXuJx
@Regeneron Reports P-II (PINNACLE) Data of Baloncibart for Postural Orthostatic Tachycardia Syndrome.
#Regeneron #Baloncibart #Phase2Trial #POTS #PosturalOrthostaticTachycardiaSyndrome #HeartRateReduction #OrthostaticSymptoms #AutonomicDisorders #Phase3Trial #PharmaShots
https://t.co/5WtMlsLEi1
The US FDA Grants Breakthrough Therapy Designation to @NervgenP NVG-291 for Chronic Cervical Spinal Cord Injury.
#NervGen #NVG291 #FDABreakthroughTherapy #SpinalCordInjury #ChronicSpinalCordInjury #CONNECTSCI #RESTORETrial #Phase3Trial #Neuroregeneration #PharmaShots
https://t.co/6UjuNcO3Ye
@VorBio Expands License Agreement with RemeGen to Add Long-Acting BAFF/APRIL Inhibitor RC298 for ~$56M Upfront.
#VorBio #RemeGen #RC298 #BAFFAPRILInhibitor #LicensingAgreement #Immunology #AutoimmuneDiseases #DrugDevelopment #300MillionMilestones #PharmaShots
https://t.co/cNQn9k9Qe7
@neurosterix Closes $105M Series B Financing to Advance NTX-253 into P-II Trial for Schizophrenia.
#Neurosterix #RTWInvestments #SeriesBFinancing #105MillionFunding #NTX253 #M4PositiveAllostericModulator #Schizophrenia #Phase2Development #Neuropsychiatry #PharmaShots
https://t.co/CUbkjqkEcO
Sandoz Launches @LupinGlobal Ranluspec (Biosimilar, Ranibizumab) Across Europe.
#Lupin #Sandoz #Ranluspec #Ranibizumab #Biosimilar #EuropeanCommissionApproval #RetinalDiseases #Ophthalmology #BiosimilarLaunch #PharmaShots
https://t.co/FtiYSModtV
@Amgen Reports P-III (OASIZ-301) Trial Data of Dazodalibep for Sjögren’s Disease.
#Amgen #Dazodalibep #Phase3Trial #SjogrensDisease #AutoimmuneDisease #SystemicDiseaseActivity #PatientReportedOutcomes #Immunology #ClinicalResearch #PharmaShots
https://t.co/0Ek45bjmGZ
@metagenomi Receives the US FDA’s IND Clearance for MGX-001 to Treat Hemophilia A.
#Metagenomi #MGX001 #FDAINDClearance #Phase12Trial #GenomeEditing #HemophiliaA #FactorVIII #GeneTherapy #INTEGR8Trial #PharmaShots
https://t.co/vQNcRes0S1
@BioNTech_Group to Acquire @ScholarRock US FDA Priority Review Voucher for $205M.
#BioNTech #ScholarRock #PriorityReviewVoucher #FDAPriorityReview #205MillionDeal #Oncology #DrugDevelopment #Biopharma #StrategicAcquisition #PharmaShots
https://t.co/apxbdbCeaI
@WatersCorp Receives the US FDA’s 510(k) Clearance for BD OneFlow LST and B-CLPD T1 Tests to Diagnose B-Cell Non-Hodgkin Lymphoma.
#Waters #BDOneFlowLST #BCLPDT1 #FDA510KClearance #FlowCytometry #BCellNonHodgkinLymphoma #CLL #CancerDiagnostics #Hematology #PharmaShots
https://t.co/rlalGINUG9
Eli Lilly to Acquire SiteOne Therapeutics for ~$1B, Strengthening its Pain Pipeline
https://t.co/ftbmoAENAm
#elililly #siteonetherapeutics #stc004 #nav18inhibitor #pii #m&a #pharmashots
GSK Reports Health Canada’s NDS Acceptance of Depemokimab for Asthma with Type 2 Inflammation and CRSwNP
https://t.co/hVVw3cK5ev
#gsk #depemokimab #healthcanada #nda #piii #swift1 #swift2 #anchor1 #anchor2 #thenejm #thelancet #regulatory #pharmashots
Gyre Therapeutics Reports P-III Trial Findings on Hydronidone for Chronic Hepatitis B-Associated Liver Fibrosis
https://t.co/xNi6zzJX6G
#gyretherapeutics #hydronidone #entecavir #ishakscore #scheuerscore #nmpa #usfda #clinicaltrial #pharmashots
BridgeBio Oncology Therapeutics (BBOT) Enters into Business Combination Agreement with Helix Acquisition Corp. II to Develop RAS and PI3Kα-Targeting Drugs
https://t.co/P9iS5U4mUR
#bridgebiooncologytherapeutics #helixacquisitioncorp #m&a #pharmashots
Ono Pharmaceutical Receives the US FDA Approval for Romvimza to Treat Symptomatic Tenosynovial Giant Cell Tumor (TGCT) in Adults
https://t.co/2RNPAW8hGO
#onopharmaceutical #romvimza #tgct #regulatory #pharmashots
The EMA Accepts MAA for ImmunityBio’s Anktiva to Treat BCG-Unresponsive Non-Muscle Invasive Bladder Cancer (NMIBC)
https://t.co/MNin7WUGJT
#immunitybio #anktiva #ema #maa #regulatory #pharmashots
Tiziana Life Sciences Identifies New Immune Biomarkers in Multiple Sclerosis Patients Treated with Foralumab
https://t.co/Ip82kONEe0
#tizianalifesciences #foralumab #multiplesclerosis #biotech #pharmashots
Agenus Highlights Data from Five Studies of Botensilimab/Balstilimab (BOT/BAL) Regimen as Multiple lines of Therapy in Colorectal Cancer at ASCO GI 2025
https://t.co/tW0yfLgGSP
#agenus #botensilimab #balstilimab #colorectalcancer #clinicaltrial #ascogi #pharmashots
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
118.7M followers
Cristiano Ronaldo
@cristiano
114.5M followers
Donald J. Trump
@realdonaldtrump
111.9M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
98.7M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91.8M followers
KATY PERRY
@katyperry
90M followers
Taylor Swift
@taylorswift13
84M followers
Lady Gaga
@ladygaga
75.5M followers
Virat Kohli
@imvkohli
73.4M followers
Kim Kardashian
@kimkardashian
70.8M followers
YouTube
@youtube
68.7M followers
Neymar Jr
@neymarjr
66.4M followers
Bill Gates
@billgates
65.2M followers
Selena Gomez
@selenagomez
63.1M followers
The Ellen Show
@theellenshow
62.2M followers
CNN
@cnn
61.7M followers
X
@x
60.6M followers